Physiological quiescence in plasma-derived serum: influence of platelet-derived growth factor on cell growth in culture
- PMID: 103885
- DOI: 10.1002/jcp.1040970325
Physiological quiescence in plasma-derived serum: influence of platelet-derived growth factor on cell growth in culture
Abstract
A platelet-derived growth factor can be shown to be the principal stimulant of DNA synthesis in whole blood serum for those cells that require serum for maintenance and growth in culture. Cell free plasma-derived serum lacks such platelet-derived material. 3T3 cells and primate arterial smooth muscle cells can be maintained in a quiescent state in culture for as long as six weeks in plasma-derived serum. Such cells can grow logarithmically after exposure to 5% whole blood serum or as little as 100 ng/ml of partially purified platelet factor. The cell cycle of smooth muscle cells has been studied in the quiescent (5% plasma-derived serum) and growing state (5% whole blood serum or 5% plasma-derived serum plus platelet factor). The generation time of smooth muscle cells is 16 to 18 hours as shown by autoradiographic frequency of labelled mitoses. The generation time is the same for cells in the growth fraction in either 5% whole blood serum or 5% plasma-derived serum. Thus, platelet factor acts by recruiting cells into the growth fraction rather than effecting a change in the duration of the cell cycle. Flow microfluorimetry studies on cells growing logarithmically in 5% whole blood serum give the following phase durations: G1 = 5.6 hours; S = 7.6 hours; and G2 + M = 3.8 hours. Based on these studies the argument is presented that cells cultured in 5% plasma-derived serum provide a more physiological base for the study of quiescence than do cells in low concentrations of whole blood serum or confluent, density inhibited cells at high (5% or greater) concentrations of whole blood serum. Furthermore, 5% plasma-derived serum represents an appropriate state to examine the perturbation of quiescent cells.
Similar articles
-
Role of platelet factors in the growth of cells in culture.Natl Cancer Inst Monogr. 1978 May;(48):103-8. Natl Cancer Inst Monogr. 1978. PMID: 748746
-
Fibroblast proliferation induced by blood cells.Agents Actions Suppl. 1980;7:81-4. Agents Actions Suppl. 1980. PMID: 6941691
-
Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: analysis using platelet-derived growth factor and platelet-poor plasma.J Cell Physiol. 1979 Jun;99(3):395-405. doi: 10.1002/jcp.1040990314. J Cell Physiol. 1979. PMID: 222785
-
Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.J Cardiovasc Pharmacol. 1993;22 Suppl 6:S64-74. J Cardiovasc Pharmacol. 1993. PMID: 7508064 Review.
-
The platelet-derived growth factor.Cell. 1978 Jun;14(2):203-10. doi: 10.1016/0092-8674(78)90107-1. Cell. 1978. PMID: 352535 Review. No abstract available.
Cited by
-
Characterization of growth factor(s) produced by chemically transformed hamster dermal fibroblasts.J Cancer Res Clin Oncol. 1985;110(2):177-80. doi: 10.1007/BF00402736. J Cancer Res Clin Oncol. 1985. PMID: 4044633
-
Adipogenic and anti-adipogenic factors in the pituitary and other organs.Proc Natl Acad Sci U S A. 1981 Jun;78(6):3969-72. doi: 10.1073/pnas.78.6.3969. Proc Natl Acad Sci U S A. 1981. PMID: 6943592 Free PMC article.
-
Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.J Clin Invest. 1983 May;71(5):1206-14. doi: 10.1172/jci110869. J Clin Invest. 1983. PMID: 6853708 Free PMC article.
-
Serial propagation of human endothelial cells in vitro.J Cell Biol. 1981 Nov;91(2 Pt 1):420-6. doi: 10.1083/jcb.91.2.420. J Cell Biol. 1981. PMID: 7309790 Free PMC article.
-
Do cancers arise from a single transformed cell or is monoclonality of tumours a late event in carcinogenesis?Br J Cancer. 1985 Apr;51(4):453-7. doi: 10.1038/bjc.1985.65. Br J Cancer. 1985. PMID: 3856454 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources